Market Place
Sourcing Support
All News #Library
Rare Diseases
Sanofi`s $1.7B Bet Beats Csl`s Zemaira In Phase 2 Face-Off
22 Oct 2025 //
FIERCE BIOTECH
CSL Behring Supports Alpha 1 Patients at AERSC
12 Sep 2018 //
PR NEWSWIRE
CSL Behring, Leader in Rare Diseases, Showcases Innovations Neuromuscular (NMM)
20 Apr 2018 //
PR NEWSWIRE
FDA OKs Hizentra for rare autoimmune disease CIDP
16 Mar 2018 //
ENDPTS
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.